Unibest
← Back to patent-cliff list

CAS 2374-03-0

(4-Carboxy-2-hydroxyphenyl)amine4-amino-3-hydroxybenzoic acid

Codes: (I)409139-2-a, (IX)409139-3-a, (V)409139-4-a, (V)409139-5-a, (VIII)409139-6-a, (IId)409139-7-a, TAFA-001, (IIIa)409139-1-a, (I)409139-10-a

Application context (from source-drug indications)

Transthyretin amyloidosisTafamidisHeart diseaseTafamidisAmyloid polyneuropathyTafamidis MeglumineTransthyretin amyloidosisTafamidis MeglumineAmyloidosisTafamidis MeglumineCardiomyopathyTafamidis MeglumineLight-chain (AL) amyloidosisTafamidis MeglumineFamilial amyloid neuropathyTafamidis Meglumine

Source drugs (routes using this intermediate)

DrugTierExpiry
TafamidisTier C — Watch / trade-
Tafamidis MeglumineTier B — Position early-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

TafamidisOptimised routesteps: 5total yield: /
(4-Carboxy-2-hydroxyphenyl)amine→Orthoformic acid trimethyl ester→1,3-Benzoxazole-6-carboxylic acid→1,3-Benzoxazole-6-carbonyl chloride→1,3-Benzoxazol-6-yl(morpholin-4-yl)methanone→1,3-Dichloro-5-iodobenzene→[2-(3,5-Dichlorophenyl)-1,3-benzoxazol-6-yl]-morpholinomethanone→2-(3,5-Dichlorophenyl)benzo[d]oxazole-6-carboxylic acid
Tafamidis MeglumineOptimised routesteps: 4total yield: 24.7 mg
4-amino-3-hydroxybenzoic acid→benzo[d]oxazole-6-carboxylic acid→benzo[d]oxazol-6-yl(morpholino)methanone→1,3-dichloro-5-iodobenzene→(2-(3,5-dichlorophenyl)benzo[d]oxazol-6-yl)(morpholino)methanone

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.